Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region

Area of Science:

• Endocrinology
• Molecular Biology
• Oncology

Background:

• Oestrogens play a crucial role in hormone-sensitive breast cancer development.
• Tissue Factor Pathway Inhibitor (TFPI) is implicated in breast cancer pathogenesis.
• Oestrogens were previously found to reduce TFPI mRNA levels in MCF7 cells via oestrogen receptor alpha (ERα).

Purpose of the Study:

• To elucidate the molecular mechanisms by which oestrogens regulate TFPI transcription.
• To investigate the interaction of ERα with the TFPI gene promoter.
• To determine the role of oestrogen response elements (ERE) in TFPI gene regulation.

Main Methods:

• Luciferase reporter assays using wild-type and mutated TFPI 5'-flanking regions.
• Electrophoretic mobility shift assays (EMSA) to assess ERα DNA binding.
• Chromatin immunoprecipitation (ChIP) to confirm in vivo ERα recruitment to the TFPI gene.

Main Results:

• Oestrogen stimulation significantly downregulated luciferase activity in cells with the wild-type TFPI promoter construct.
• Mutating ERE half-sites abolished the oestrogen-mediated downregulation of TFPI transcription.
• EMSA and ChIP assays confirmed direct binding of ERα to ERE half-sites in the TFPI promoter and in vivo recruitment.

Conclusions:

• Oestrogen receptor alpha directly interacts with three ERE half-sites in the TFPI 5'-flanking region.
• ERα mediates the repression of oestrogen-induced TFPI transcription in breast cancer cells.
• These findings reveal a novel mechanism of TFPI regulation by oestrogens in breast cancer.